This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jakobsen, H.
Right arrow Articles by Jónsdóttir, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jakobsen, H.
Right arrow Articles by Jónsdóttir, I.

 Previous Article  |  Next Article 

Infection and Immunity, November 1999, p. 5892-5897, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines with Nontoxic Mutants of Escherichia coli Heat-Labile Enterotoxins as Adjuvants Protects Mice against Invasive Pneumococcal Infections

Håvard Jakobsen,1 Dominique Schulz,2 Mariagrazia Pizza,3 Rino Rappuoli,3 and Ingileif Jónsdóttir1,*

National University Hospital, Department of Immunology, 101 Reykjavík, Iceland1; Pasteur Mérieux Connaught, Marcy l'Etoile, France2; and Immunobiology Research Institute Siena, 53100 Siena, Italy3

Received 6 May 1999/Returned for modification 16 July 1999/Accepted 27 August 1999

Host defenses against Streptococcus pneumoniae depend largely on phagocytosis following opsonization by polysaccharide-specific immunoglobulin G (IgG) antibodies and complement. Since colonization of the respiratory mucosa is the first step in pneumococcal pathogenesis, mucosal immune responses may play a significant role. In addition to inducing systemic immune responses, mucosal vaccination with an effective adjuvant has the advantage of inducing mucosal IgA antibodies. The heat-labile enterotoxin (LT) of Escherichia coli is a well-studied mucosal adjuvant, and adjuvant activity of nontoxic LT mutants has been demonstrated for several protein antigens. We investigated the immunogenicity of pneumococcal polysaccharide conjugate vaccines (PNC) of serotypes 1 and 3 in mice after intranasal (i.n.) immunization by using as an adjuvant the nontoxic LT mutant LT-K63 or LT-R72, which has minimal residual toxicity. Pneumococcal serotype-specific antibodies were measured in serum (IgM, IgG, and IgA) and saliva (IgA), and vaccine-induced protection was evaluated by i.n. challenge with virulent pneumococci of the homologous serotype. When administered with LT mutants, i.n. immunization with both conjugates induced systemic and mucosal immune responses, and serum IgG antibody levels were significantly higher than after subcutaneous immunization. All mice immunized i.n. with PNC-1 and LT mutants were protected against bacteremia and cleared the pneumococci from the lung 24 h after i.n. challenge; pneumococcal density correlated significantly with serum IgG antibody levels. Similarly, the survival of mice immunized i.n. with PNC-3 and LT mutants was significantly prolonged. These results demonstrate that i.n. vaccination with PNC and potent adjuvants can protect mice against invasive and lethal pneumococcal infections, indicating that mucosal vaccination with PNC may be an alternative vaccination strategy for humans.

* Corresponding author. Mailing address: Department of Immunology, National University Hospital, 101 Reykjavík, Iceland. Phone: 354-5601962. Fax: 354-5601943. E-mail: ingileif{at}rsp.is.

Infection and Immunity, November 1999, p. 5892-5897, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Matthias, K. A., Roche, A. M., Standish, A. J., Shchepetov, M., Weiser, J. N. (2008). Neutrophil-Toxin Interactions Promote Antigen Delivery and Mucosal Clearance of Streptococcus pneumoniae. J. Immunol. 180: 6246-6254 [Abstract] [Full Text]  
  • Richter, M. Y., Jakobsen, H., Haeuw, J.-F., Power, U. F., Jonsdottir, I. (2005). Protective Levels of Polysaccharide-Specific Maternal Antibodies May Enhance the Immune Response Elicited by Pneumococcal Conjugates in Neonatal and Infant Mice. Infect. Immun. 73: 956-964 [Abstract] [Full Text]  
  • Finn, A. (2004). Bacterial polysaccharide-protein conjugate vaccines. Br Med Bull 70: 1-14 [Abstract] [Full Text]  
  • Apostolaki, M., Williams, N. A. (2004). Nasal Delivery of Antigen with the B Subunit of Escherichia coli Heat-Labile Enterotoxin Augments Antigen-Specific T-Cell Clonal Expansion and Differentiation. Infect. Immun. 72: 4072-4080 [Abstract] [Full Text]  
  • Richter, M. Y., Jakobsen, H., Birgisdottir, A., Haeuw, J.-F., Power, U. F., Del Giudice, G., Bartoloni, A., Jonsdottir, I. (2004). Immunization of Female Mice with Glycoconjugates Protects Their Offspring against Encapsulated Bacteria. Infect. Immun. 72: 187-195 [Abstract] [Full Text]  
  • Wernette, C. M., Frasch, C. E., Madore, D., Carlone, G., Goldblatt, D., Plikaytis, B., Benjamin, W., Quataert, S. A., Hildreth, S., Sikkema, D. J., Kayhty, H., Jonsdottir, I., Nahm, M. H. (2003). Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides. CVI 10: 514-519 [Full Text]  
  • Jakobsen, H., Sigurdsson, V. D., Sigurdardottir, S., Schulz, D., Jonsdottir, I. (2003). Pneumococcal Serotype 19F Conjugate Vaccine Induces Cross-Protective Immunity to Serotype 19A in a Murine Pneumococcal Pneumonia Model. Infect. Immun. 71: 2956-2959 [Abstract] [Full Text]  
  • Jiao, X., Hirano, T., Hou, Y., Gu, X.-X. (2002). Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate Vaccine. Infect. Immun. 70: 5982-5989 [Abstract] [Full Text]  
  • Jakobsen, H., Bjarnarson, S., Del Giudice, G., Moreau, M., Siegrist, C.-A., Jonsdottir, I. (2002). Intranasal Immunization with Pneumococcal Conjugate Vaccines with LT-K63, a Nontoxic Mutant of Heat-Labile Enterotoxin, as Adjuvant Rapidly Induces Protective Immunity against Lethal Pneumococcal Infections in Neonatal Mice. Infect. Immun. 70: 1443-1452 [Abstract] [Full Text]  
  • Kong, Q., Richter, L., Yang, Y. F., Arntzen, C. J., Mason, H. S., Thanavala, Y. (2001). Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 10.1073/pnas.191617598v1 [Abstract] [Full Text]  
  • Bonenfant, C., Dimier-Poisson, I., Velge-Roussel, F., Buzoni-Gatel, D., Del Giudice, G., Rappuoli, R., Bout, D. (2001). Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice against Toxoplasma gondii. Infect. Immun. 69: 1605-1612 [Abstract] [Full Text]  
  • Shen, X., Lagergard, T., Yang, Y., Lindblad, M., Fredriksson, M., Holmgren, J. (2001). Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization. Infect. Immun. 69: 297-306 [Abstract] [Full Text]  
  • Kong, Q., Richter, L., Yang, Y. F., Arntzen, C. J., Mason, H. S., Thanavala, Y. (2001). Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 98: 11539-11544 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»